Genomic platforms for cancer research: Potential diagnostic and prognostic applications in clinical oncology

Clinical and Translational Oncology

Volumn 8, Issue 3, 2006, Pages 161-172

  Jares, Pedro ^a   Campo, Elías ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

DNA microarrays; Genomics and neoplasms

Indexed keywords

COMPLEMENTARY DNA; TRANSCRIPTOME; DNA;

ARTICLE; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER GENETICS; CANCER RESEARCH; CANCER SURVIVAL; CLINICAL PRACTICE; DNA METHYLATION; DNA MICROARRAY; DNA SEQUENCE; EXON; GENE EXPRESSION PROFILING; GENETIC DATABASE; GENETIC VARIABILITY; GENOTYPE; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN GENOME; ONCOLOGY; PROGNOSIS; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SOLID TUMOR; GENETICS; GENOMICS; MEDICAL RESEARCH; METHODOLOGY; NEOPLASM; REVIEW;

BIOMEDICAL RESEARCH; DNA, NEOPLASM; GENE EXPRESSION PROFILING; GENOMICS; HUMANS; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS;

EID: 33747117743     PISSN: 1699048X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12094-006-0006-z     Document Type: Article

References (83)

1. Lander ES, Linton LM, Birren B, et al. Initial sequencing and analysis of the human genome. Nature. 2001;409:(6822):860-921.
2. Venter JC, Adams MD, Myers EW, et al. The sequence of the human genome. Science. 2001;29(5507):1304-51.
3. Southern E, Mir K, Schepinov M Molecular interactions on microarrays Nat Genet. 1999;21(1 Suppl):S5-9.
4. Holloway AL, van Laar RK, Tothil RW, Bowtell DD. Options available-from start to finish- for obtaining data from DNA microarrays II. Nat Genet. 2002;32Suppl:481-9.
5. Schena M, Heller RA, Theriault TP, Konrad K, Lachenmaier E, Davis RW Microarrays: Biotechnology's discovery platform for functional genomics. Trends Biotechnol. 1998;16(7):301-6.
6. Barrett JC, Kawasaki ES. Microarrays: The use of oliganucleotides and cDNA for the analysis of gene expression. Drug Discov Today. 2005;8(3):134-41.
7. Granijeaud S, Bertucci F, Jordan BR. Expression profiling: DNA arrays in many guises. Bioessays. 1999;21(9):781-90.
8. Schena M, Shalon D, Davis RW, Brown PO. Quantitative monitoring of gene expression patterns with a complementary DNA microarrays. Science. 1995;270(5235): 467-70.
9. Cheung VG, Morley M, Aguilar F, Massimi A, Kucherlapati R, Childs G. Making and reading microarrays. Nat Genet. 1999; 21(Suppl):S15-9.
10. Duggan DJ, Bittner M, Chen Y, Meltzer P, Trent JM. Expression profiling using cDNA microarrays. Nat Genet. 1999;21(1 Suppl):S10-4.
11. Hughes TR, Mao M, Jones AR, et al. Expression profiling using microarrays fabricated by an ink-jet oligonucleotide synthesizer. Nat Biotechnol. 2001;19(4):342-7.
12. Sendera TJ, Dorris D, Ramakrishnan R, Nguyen A, Trakas D, Mazumder A. Expression profiling with oligonucleotide arrays: Technologies and applications for neurobiology. Neurochem Res. 2002;27(10): 1005-26.
13. Lipshutz RJ, Fodor SP, Gingeras TR, Lockhart DJ. High density synthetic oligonucleotide arrays. Nat Genet. 1999;21 (1 Suppl):S20-4.
14. Fodor SP, Read JL, Pirrung MC, Stryer L, Lu AT, Solas D. Ligh-directed, spatially addressable parallel chemical synthesis. Science. 1991;251(4995):767-73.
15. Ramakrishnan R, Dorris D, Lublinsky A, et al. An assessment of Motorola CodeLink Microarray performance for gene expression profiling applications. Nucleic Acids Res. 2002;30(7):50.
16. Shippy R, Sendera TJ, Lockner R, et al. Performance evaluation of commercial short-oligonucleotide microarrays and the impact of noise in making cross-platform correlations. BMC Genomics. 2004;55 (1):61.
17. Nuwaysir EF, Huang W, Albert TJ, et al. Gene expression analysis using oligonueleotide arrays produced by maskless photolithography. Genome Res. 2002;12(11): 1749-55.
18. Bracco L and Kearsey J. The relevance of alternative RNA splicing to pharmacogenomics. Trends Biotechnol. 2003;21(8): 346-55.
19. Clark TA, Sugnet CW, Ares MJr. Genomewide analysis of mRNA processing in yeast using splicing-specific microarrays. Science. 2002;296(5569):907-10.
20. Johnson JM, Castle J, Garrett-Engele P, et al. Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. Science. 2005;502 (5655):2141-4
21. Kapranov P, Cawley SE, Drenkow J, et al. Large-scale transcriptional activity in chromosones 21 and 22. Science. 2002;296 (5569):916-9.
22. Rinn JL, Euskirchen G, Bertone P, et al. The transcriptional activity of human Chromosome 22. Genes Dev. 2003;17(4): 529-40.
23. Bertone P, Stolc V, Royce TE, et al. Global identification of human transcribed sequences with genome tiling arrays. Science. 2004;306(5705):2242-6.
24. Cheng J, Kapranov P, Drenkow J, et al. Transcriptional maps of 10 human chromosomes at 5-nucleotide resolution. Science. 2005;308(5725):1149-54.
25. Mir KU and Southern EM. Sequence variation in genes and genomic DNA: methods for large-scale analysis. Annu Rev Genomics Hum Genet. 2000;1:329-60.
26. Kruglyak L, Nickerson DA Variation is the spice of life. Nat Genet. 2001;27(3): 234-6.
27. Negm RS, Verma M, Srivastava S. The promise of biomarkers in cancer screening and detection. Trends Mol Med. 2002;8 (6):288-95.
28. Kristensen VN, Kelefiotis D, Kristensen T, Borresen-Dale AL. High-throughput methods for detection of genetic variation. Biotechniques. 2001;50(2):318-22, 24, 26.
29. Wang DG, Fan JB, Siao CJ, et al. Largescale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome. Science. 1998;280(5366):1077-82.
30. Warrington JA, Shah NA, Chen X, et al. New developments in high-throughput resequencing and variation detection using high density microarrays. Hum Mutat. 2002;19(4):402-9.
31. Pastinen T, Kurg A, Metspalu A, Peltonen L, Syvanen AC. Minisequencing: a specific tool for DNA analysis and diagnostics on oligonucleotide arrays. Genome Res. 1997;7(6):606-14.
32. Pastinen T, Raitio M, Lindroos K, Tainola P, Peltonen L, Syvanen AC. A system for specific, high-throughput genotyping by allele-specific primer extension on microarrays. Genome Res. 2000;10(7):1031-42.
33. Fan JB, Chen X, Halushka MK, et al. Parallel genotyping of human SNPs using generic high-density oligonucleotide tag arrays. Genome Res. 2000;10(6):853-60.
34. Hardenbol P, Yu F, Belmont J, et al. Highly multiplexed molecular inversion probe genotyping: Over 10,000 targeted SNPs genome Res. 2005;15(2):269-75.
35. Shen R, Fan JB, Campbell D, et al. High-throughput SNP genotyping on universal bead arrays. Mutat Res. 2005;573(1-2):70-82.
36. Kennedy GC, Matsuzaki H, Dong S, et al. Large-scale genotyping of complex DNA. Nat Biotechnol. 2003;21(10):1233-7.
37. Matsuzaki H, Loi H, Dong S, et al. Parallel genotyping of over 10,000 SNPs using a one-primer assay on a high-density oligonucleotide array. Genome Res. 2004;14(3): 414-25.
38. Matsuzaki H, Dong S, Loi H, et al. Genolyping over 100,000 SNPs on a pair of oligonucleotide arrays. J Nat Methods. 2004;1 (2):109-11.
39. Di X, Matsuzaki H, Webster TA, et al. Dynamic model based algorithms for screening and genotyping over 100 K SNPs on oligonucleotide microarrays. Bioinformatics. 2005;21(9):1958-63.
40. Puffenberger EG, Hu-Lince D, Parod JM, et al. Mapping of sudden infant death with dysgenesis of the testes syndrome (SIDDT) by a SNP genome scan and identification of TSPYL loss of function. Proc Natl Acad Sci USA. 2004;101(32):11689-94.
41. Klein RJ, Zeiss C, Chew EY, et al. Complement factor H polymorphism in agerelated macular degeneration. Science. 2005;308(5720):385-9.
42. Hacia JG. Resequencing and mutational analysis using oligonucleotide microarrays. Nat Genet. 1999;21(1 Suppl): S42-7.
43. Hacia JG, Sun B, Hunt N, et al. Strategies for mutational analysis of the large multiexon ATM gene using high-density oligonucleotide arrays. Genome Res. 1998;8 (12):1245-58.
44. Ahrendt SA, Halachmi S, Chow JT, et al. Rapid p53 sequence analysis in primary lung cancer using an oligonucleotide probe array. Proc Natl Acad Sci USA. 1999;96(15):7382-7.
45. Kallioniemi A, Kallioniemi OP, Sudar D, et al. Comparative genomic hydridization for molecular cytogenetic analysis of solid tumors. Science. 1992;258(5085):818-21.
46. Solinas-Toldo S, Lampel S, Stilgenbauer S, et al. Matrix-based comparative genomic hybridization: Biochips to screen for genomic imbalances. Genes Chromosomes Cancer. 1997;20(4):399-407.
47. Fiegler H, Carr P, Douglas EJ, et al. DNA microarrays for comparative genomic hybridization based on DOP-PCR amplification of BAC and PAC clones. Genes Chromosomes Cancer. 2003;36(4):361-74.
48. Cai WW, Mao JH, Chow CW, Damani S, Balmain A, Bradley A. Genome-wide detection of chromosomal imbalances in tumors using BAC microarrays. Nat Biotechnol. 2002;20(4):393-6.
49. Pollack JR, Perou CM, Alizadeh AA, et al. Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nat Genet. 1999;23(1):41-6.
50. Krzywinski M, Bosdet I, Smailus D, et al. A set of BAC clones spanning the human genome. Nucleic Acids Res. 2004;32(12): 3651-60.
51. Barrett MT, Scheffer A, Ben Dor, A et al. Comparative genomic hybridization using oligonucleotide microarrays and total genomic DNA. Proc Natl Acad Sci USA. 2004;101(51):17765-70.
52. Selzer RR, Richmond TA, Pofahl NJ, et al. Analysis of chromosome breakpoints in neuroblastoma at sub-kilobase resolution using fine-tiling oligonucleotide array CGH. Genes Chromosomes Cancer. 2005;44 (3):505-19.
53. Huang J, Wei W, Zhang J, et al. Whole genome DNA copy number changes identified by high density oligonucleotide arrays. Hum Genomics. 2004;1(4):287-99.
54. Nannya Y, Sanada M, Nakazaki K, et al. A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays. Cancer Res. 2005;65(14):6071-9.
55. Bignell GR, Huang J, Greshock J, et al. High-resolution analysis of DNA copy number using oligonucleotide microarrays. Genome Res. 2004;14(2):287-95.
56. Zhao X, Li C, Paez JG, et al. An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arrays. Cancer Res. 2004;64(9):3060-71.
57. Antequera F, Bird A. Number of CpG islands and genes in human and mouse. Proc Natl Acad Sci USA. 1995;90(24): 11995-9.
58. Herman JG, Graff JB, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA. 1996;93(18):9821-6.
59. Plass C: Cancer epigenomics. Hum Mol Genet. 2002;11(20):2479-88.
60. Cameron EE, Bachman KE, Myohanen S, Herman JG, Baylin SB. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet. 1999;21(1): 103-7.
61. Lodygin D, Epanchintsev A, Menssen A, Diebold J, Hermeking H. Functional epigenomics identifies genes frequently silenced in prostate cancer. Cancer Res. 2005;65(10):4218-27.
62. Yamashita K, Upadhyay S, Osada M, et al. Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma. Cancer Cell. 2002;2(6):485-95.
63. Adorjan P, Distler J, Lipscher E, et al. Tumour class prediction and discovery by microarray -based DNA methylation analysis. Nucleic Acids Res. 2002;30(5): E21.
64. Yan PS, Chen CM, Shi H, et al. Dissecting complex epigenetic alterations in breast cancer using CpG island microarrays. Cancer Res. 2001;61(23):8375-80.
65. Yan PS, Perry MR, Laux DE, Asare AL, Caldwell CW, Huang TH. CpG island arrays: An application toward deciphering epigenetic signatures of breast cancer. Clin Cancer Res. 2000;6(4):1432-8.
66. Gitan RS, Shi H, Chen CM, Yan PS, Huang TH. Methylation-specific oligonucleotide microarrays: A new potential for high-throughput methylation analysis. Genome Res. 2002;12(1):158-64.
67. Hatada I, Kato A, Morita S, et al. A microarrays -based method for detecting methylated loci. J Hum Genet. 2002;47 (8):448-51.
68. Weber M, Davies JJ, Wittig D, et al. Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat Genet. 2005:37(8):853-62.
69. Golub TR, Slonim DK, Tamayo P, et al. Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring. Science. 1999;286 (5439):531-7.
70. Armstrong SA, Staunton JE, Silverman LB, et al. MLL translocations specity a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet. 2002;30(1):41-7.
71. Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000;403(6769):505-11.
72. Bea S, Zettl A, Wright G et al. Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction. Blood. 11-1-2005; 106(9):3185-90.
73. Rosenwald A, Wright G, Wiestner A, et al. The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell. 2003; 3(2):185-97.
74. Rosenwald A, Alizadeh AA, Widhopf G, et al. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med. 12-3-2001;194(11):1659-47.
75. Dave SS, Wright G, Tan B, et al. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med. 2004;351(21):2159-69.
76. Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumors. Nature. 2000 406:(6797):747-52.
77. Veer LJ, Dai H, van de Vijver MJ, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature. 2002;415(6871):530-6.
78. van de Vijver MJ, He YD, van't Veer LJ, et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002;347:(25):1999-2009.
79. Eden P, Ritz C, Rose C, Ferno M, Peterson C. "Good Old" clinical markers have similar power in breast cancer prognosis as microarray gene expression profilers Eur J Cancer. 2004;40(12):1837-41.
80. Minn AJ, Gupta GP, Siegel PM, et al. Genes that mediate breast cancer metastasis to lung. Nature. 2005;456(7050):518-24.
81. Rosenwald A, Wright G, Chan WC, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med. 2002;346(25):1937-47.
82. Lossos IS, Czerwinski DK, Alizadeh AA, et al. Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes. N Engl J Med. 2004; 350(18):1828-37.
83. Crespo M, Bosch F, Villamor N, et al. ZAP-70 expression as a surrogale for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. N Engl J Med. 2003;348(18):1764-75.